Co-drug delivery of regorafenib and cisplatin with amphiphilic copolymer nanoparticles: enhanced in vivo antitumor cancer therapy in nursing care

HIGHLIGHTS: Dual drug delivery of Regorafenib (REGO) and Cisplatin (PT) exhibits a great anticancer potential, as REGO enhances the effect of PT treatment of human cells by providing stability of the microenvironment. REGO-PT NPs induced significant apoptosis in human lung A549 and ovarian A2780 can...

Descripción completa

Detalles Bibliográficos
Autor principal: Zhou, Zhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534345/
https://www.ncbi.nlm.nih.gov/pubmed/32936009
http://dx.doi.org/10.1080/10717544.2020.1815897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534345/
https://www.ncbi.nlm.nih.gov/pubmed/32936009
http://dx.doi.org/10.1080/10717544.2020.1815897

Ejemplares similares